LSTM Home > LSTM Research > LSTM Online Archive

Global antimicrobial stewardship and the need for pharmaceutical system strengthening for antimicrobials within a One Health approach

Villacorta Linaza, Rocio, Genovezos, Chantelle, Garner, Timothy, Panford-Quainoo, Edwin and Roberts, Adam ORCID: https://orcid.org/0000-0002-0760-3088 (2022) 'Global antimicrobial stewardship and the need for pharmaceutical system strengthening for antimicrobials within a One Health approach'. International Journal of Pharmacy Practice. (In Press)

[img] Image
Figure 1_JPEG.jpeg - Supplemental Material
Restricted to Repository staff only until 23 March 2023.

Download (77kB)
[img] Image
Figure 2_JPEG.jpeg - Supplemental Material
Restricted to Repository staff only until 23 March 2023.

Download (110kB)
[img] Text
Int_J_Pharm_Pract_ria012.pdf - Accepted Version
Restricted to Repository staff only until 23 March 2023.

Download (153kB)

Abstract

Objectives
The Covid-19 pandemic has highlighted both the vulnerabilities and the critical role of global pharmaceutical systems in enabling equitable access to medicines. In this personal view, we position the pharmaceutical system as a missed research and investment opportunity that, if integrated properly, would benefit antimicrobial stewardship (AMS) programmes within a One Health approach.
Key findings
The pharmaceutical supply management cycle (PSMC) illustrates the continuous interdependence between four key phases - selection, procurement, distribution and use. Furthermore, a PSMC is subject to external forces of market competition, policy and regulation - across human, animal and environmental health. We present examples of overlap in PSMCs across different One Health sectors and discuss the need for integration within human, animal and environmental health contexts.
Summary
Despite pharmaceutical systems being fundamental to successful AMS programmes they are currently neglected and undervalued. Research and investment into pharmaceutical system optimisation and integration into AMS programmes presents an opportunity for both high income countries and low- and middle-income countries, to develop responsible, comparable and international AMS innovations and interventions.

Item Type: Article
Subjects: QV Pharmacology > Drug Standardization. Pharmacognosy. Medicinal Plants > QV 771 Standardization and evaluation of drugs
QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified.
WA Public Health > Health Administration and Organization > WA 530 International health administration
Faculty: Department: Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI): https://doi.org/10.1093/ijpp/riac012
Depositing User: Marie Hatton
Date Deposited: 29 Mar 2022 12:26
Last Modified: 29 Mar 2022 12:26
URI: https://archive.lstmed.ac.uk/id/eprint/19883

Statistics

View details

Actions (login required)

Edit Item Edit Item